Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases

A Bodaghi, N Fattahi, A Ramazani - Heliyon, 2023 - cell.com
The use of biomarkers as early warning systems in the evaluation of disease risk has
increased markedly in the last decade. Biomarkers are indicators of typical biological …

Sex and gender differences in myocarditis and dilated cardiomyopathy: an update

DL Fairweather, DJ Beetler, N Musigk… - Frontiers in …, 2023 - frontiersin.org
In the past decade there has been a growing interest in understanding sex and gender
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …

Home‐based versus centre‐based cardiac rehabilitation

STJ McDonagh, H Dalal, S Moore… - Cochrane database …, 2023 - cochranelibrary.com
Background Cardiovascular disease is the most common cause of death globally.
Traditionally, centre‐based cardiac rehabilitation programmes are offered to individuals after …

Sex and age differences in AMPK phosphorylation, mitochondrial homeostasis, and inflammation in hearts from inflammatory cardiomyopathy patients

ML Barcena, G Tonini, N Haritonow, P Breiter… - Aging …, 2023 - Wiley Online Library
Linked to exacerbated inflammation, myocarditis is a cardiovascular disease, which may
lead to dilated cardiomyopathy. Although sex and age differences in the development of …

Positive airway pressure therapy adherence and health care resource use in patients with obstructive sleep apnea and heart failure with preserved ejection fraction

PA Cistulli, A Malhotra, KV Cole, AS Malik… - Journal of the …, 2023 - Am Heart Assoc
Background Obstructive sleep apnea (OSA) is common in heart failure with preserved
ejection fraction (HFpEF). However, current evidence is equivocal regarding the potential …

Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from …

F Guidetti, LH Lund, L Benson, C Hage… - European Journal of …, 2023 - Wiley Online Library
ABSTRACT Aims Mineralocorticoid receptor antagonists (MRAs) improve outcomes in heart
failure with reduced ejection fraction (HFrEF) but remain underused and are often …

The therapeutic value of bifidobacteria in cardiovascular disease

J Tang, Y Wei, C Pi, W Zheng, Y Zuo, P Shi… - npj Biofilms and …, 2023 - nature.com
There has been an increase in cardiovascular morbidity and mortality over the past few
decades, making cardiovascular disease (CVD) the leading cause of death worldwide …

Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure

MT Gürgöze, LC Van Vark, SJ Baart… - Circulation: Heart …, 2023 - Am Heart Assoc
Background: Studies on serially measured GDF-15 (growth differentiation factor 15) in acute
heart failure (HF) are limited. Moreover, several pathophysiological pathways contribute to …

Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy

J Malgie, PRD Clephas, HP Brunner-La Rocca… - Heart Failure …, 2023 - Springer
Multiple landmark trials have helped to advance the treatment of heart failure with reduced
ejection fraction (HFrEF) significantly over the past decade. These trials have led to the …

Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer's disease

A Elia, S Fossati - Frontiers in Physiology, 2023 - frontiersin.org
The heart is a functional syncytium controlled by a delicate and sophisticated balance
ensured by the tight coordination of its several cell subpopulations. Accordingly …